Starting a supplement brand in the United States means building a regulated product business, not buying a stock formula and adding a label.

The safest order is to define the customer, check the economics, clear the name, establish the regulatory route, qualify the manufacturer, develop the product, approve the claims and label, release the batch, and only then sell it. Work done out of order usually has to be paid for twice.

This guide is for founders preparing a serious US supplement brand in capsules, tablets, powders, liquids, softgels, or gummies. It covers the decisions a founder must own, the work that can be delegated, and the documents that should exist before launch.

This is a business and design planning guide, not legal, medical, tax, or regulatory advice. Have qualified professionals review your product classification, ingredients, claims, label, contracts, tax position, and state obligations.

The short answer

To start a supplement brand in the US:

1. Define one customer and one recurring problem.

2. Choose a clear market position and first product.

3. Model landed cost, margin, cash needs, and reorder timing.

4. Form the business, insure it, and clear the brand name.

5. Confirm that the product and every ingredient have a lawful route to market.

6. Decide what the brand can claim and collect supporting evidence.

7. Qualify a contract manufacturer and sign a quality agreement.

8. Develop the formula, specifications, test plan, and shelf-life basis.

9. Build the identity and packaging system around the approved product.

10. Complete the label, testing, batch review, and product release.

11. Prepare the store, marketplace documents, complaint process, and launch plan.

12. Use the first 90 days to improve the product and operation before scaling.

A straightforward product made with established ingredients and stock packaging may reach market in roughly six to nine months. A novel ingredient, custom gummy, certification program, original study, custom component, or difficult stability profile can add substantial time.

What the FDA does and does not approve

Most dietary supplements do not receive FDA approval before sale. FDA also does not routinely approve their labels or advertising before launch.

That does not remove responsibility from the brand. The company introducing the product into commerce is responsible for lawful ingredients, safety, compliant manufacturing, accurate labels, supported claims, complaint handling, and serious adverse-event reporting.

Dietary supplements are regulated as a category of food under the Dietary Supplement Health and Education Act of 1994. A product presented as diagnosing, treating, curing, mitigating, or preventing a disease may be treated as a drug regardless of the words used to describe the company.

A useful distinction:

• A facility registration concerns a facility. It is not product approval.

• An NDI notification is a premarket notification for certain new dietary ingredients. It is not an approval certificate.

• A structure/function notification tells FDA that a qualifying claim is being used. It does not mean FDA endorses the claim.

• A third-party certification applies to the scope stated by the certifier. It does not replace the brand's legal duties.

As of July 12, 2026, federal mandatory product listing for dietary supplements remains proposed rather than enacted. H.R. 8370, the Dietary Supplement Listing Act of 2026, was introduced on April 20, 2026 and referred to the House Committee on Energy and Commerce. Keep orderly product records, but do not describe a proposed listing system as current law.

1. Define the customer and problem

“Wellness consumers” is too broad to guide a product, price, formula, or package.

Describe the customer through a recurring situation. For example:

• A night-shift clinician whose sleep schedule changes every week

• A person using a GLP-1 medication who is trying to maintain adequate protein and micronutrient intake under professional guidance

• A recreational endurance athlete training in hot weather

• An adult who wants a simple magnesium product and finds multi-ingredient blends hard to evaluate

Interview 15 to 20 people who match the intended buyer. Ask about behaviour rather than opinions:

• What do they use now?

• What causes them to start looking for a product?

• What makes them stop taking one?

• Which claims or ingredients make them suspicious?

• Which format fits their routine?

• What do they pay without needing a discount?

• What did they buy before, and why did they switch?

Read one-star, three-star, and recent reviews across the category. One-star reviews often reveal product failures. Three-star reviews are useful because they show where a product was acceptable but incomplete.

Also list the substitutes. A supplement may compete with food, a routine, a prescription product, a beverage, another supplement, or no action at all.

Write the first working brief in one sentence:

For [specific customer], this product supports [specific outcome] through [credible product, format, or routine advantage].

Decision gate: Continue only when a defined group is already spending money, time, or effort on the problem and you can explain why they would switch.

2. Choose the position and first product

Positioning tells the customer how to place the brand in a crowded category.

Settle five points:

1. Category: What does the customer compare it with?

2. Customer: Who should recognise themselves immediately?

3. Use case: When and why is the product taken?

4. Proof: What makes the promise believable?

5. Boundary: What will the brand refuse to become?

“Science-backed wellness” leaves all five unanswered. A position such as “a once-daily protein and micronutrient routine for adults using GLP-1 medication” is narrower, easier to test, and easier to design around. The product and claims would still require clinical and regulatory review, but the commercial idea is clear.

Choose the first SKU at the same time. A founder often adds ingredients to create more claims. That can raise cost, expand the Supplement Facts panel, make testing harder, increase interaction risk, and weaken the main reason to buy.

For a first launch, one well-defined product is usually easier to manufacture, explain, stock, advertise, and improve. Start with several SKUs only when the routine genuinely requires them and the cash plan can carry separate inventory for each.

Decision gate: A person in the target group can identify the product, intended customer, and main difference after one short explanation.

3. Build the financial model

Do this before approving a formula or requesting a large run.

Calculate the landed cost of one sellable unit. Include:

• Formula and manufacturing

• Bottle, pouch, blister, closure, scoop, dropper, desiccant, and seal

• Label, carton, insert, and shipper

• Testing, certification, and product-release costs

• Freight into the warehouse

• Import duties and brokerage where relevant

• Warehousing, pick-and-pack, postage, and returns

• Payment processing and marketplace fees

• Discounts, samples, affiliate commissions, and refunds

• Insurance, regulatory review, and other professional costs

Then model each channel separately. DTC, Amazon, and wholesale can produce very different contribution margins from the same bottle.

The essential figures are:

• Landed cost per sellable unit

• Contribution margin after fulfilment and channel costs

• Break-even customer acquisition cost

• Cash conversion cycle

• Reorder point and deposit requirement

• Months of inventory under a slow-sales case

Build a downside case. Use slower sales, a production delay, higher freight, a deeper launch discount, more returns, and a reorder deposit due before the first run has sold through.

A low unit price can hide a poor cash decision. Ten thousand discounted units are more expensive than two thousand full-cost units if most of the larger order expires, is reworked, or no longer matches the product customers want.

Decision gate: The business still has enough cash to operate and reorder when the realistic case performs worse than the launch forecast.

4. Set up the company and clear the name

Choose the entity and tax structure with qualified advisors. The practical setup commonly includes:

• Forming the entity in the appropriate state

• Obtaining an EIN and required state tax accounts

• Opening separate banking and accounting systems

• Registering for sales tax where the business has nexus

• Checking state and local licences or permits

• Signing founder, contractor, advisor, and intellectual-property agreements

• Purchasing general and product-liability insurance before sale

Clear the brand name before investing in identity, packaging, photography, or inventory.

Use a layered process:

1. Search the web, marketplaces, retailers, social platforms, and domain records.

2. Search the USPTO database for identical and confusingly similar marks.

3. Review relevant classes, goods, services, sounds, spellings, and meanings.

4. Ask trademark counsel to complete a proper clearance review.

5. File through the USPTO Trademark Center when the mark is defensible.

A free domain is not evidence that a mark is available. A name can also be a poor choice even when it is legally available: hard to pronounce, too close to a category cliché, easy to misspell, or too narrow for future products.

Decision gate: The entity can trade, the risk is insured, and counsel is comfortable with the naming plan.

5. Confirm the product and ingredient route

Before final formulation, confirm that the intended product qualifies as a dietary supplement and that each dietary ingredient has a lawful basis for use.

Build an ingredient file containing:

• Common, scientific, and branded names

• Botanical part, strain, salt, chemical form, or extract ratio where relevant

• Supplier and manufacturing source

• Amount per serving and expected daily intake

• Identity and purity specifications

• Safety evidence for the dose and intended population

• Known allergens, interactions, contraindications, and warning needs

• Evidence of US marketing history before October 15, 1994, if claimed

• New dietary ingredient assessment

• Supplier documentation and prior FDA correspondence where relevant

If a dietary ingredient was not marketed in the United States before October 15, 1994, the manufacturer or distributor may need to submit a new dietary ingredient notification unless an exception applies. The notification generally must reach FDA at least 75 days before the product is introduced or delivered for introduction into interstate commerce.

Do not close this review because a supplier says an ingredient is compliant. Ask for the underlying evidence. Novel extracts, unusual delivery systems, peptides, drug-adjacent substances, and ingredients with changing FDA positions deserve particular care.

The finished product also matters. Safety support for isolated ingredients does not automatically establish that a combination, dose, delivery system, or target population is appropriate.

Decision gate: A regulatory professional can state the product category and explain the route, dose, warnings, and evidence for every ingredient.

6. Decide the claims before final formulation

Claims affect the formula, dose, evidence, name, label space, product page, ads, creator scripts, and customer-support language. They should be written before the formula is locked.

Common categories include:

• Structure/function claims: Describe support for normal body structure or function, such as “supports muscle recovery.”

• Nutrient-content claims: Describe the amount or level of a nutrient under defined rules.

• Health claims: Describe a relationship between a substance and reduced risk of a disease under specific authorisation or qualification rules.

• Disease claims: State or imply diagnosis, treatment, mitigation, cure, or prevention of disease. These can cause the product to be treated as an unapproved drug.

Create an approved claim library. For each statement, record:

• Exact wording

• Where it may appear

• Ingredient and dose connected to the statement

• Intended population

• Supporting studies and limitations

• Required disclaimer or qualification

• Review and approval date

• Prohibited variants that overstate the evidence

The FTC evaluates the full advertising impression. Product names, images, testimonials, before-and-after material, search metadata, creators, and sales scripts can create a claim even when the label uses cautious wording.

Health-related advertising must be truthful, not misleading, and supported by competent and reliable scientific evidence. Evidence should fit the actual ingredient, dose, population, use, and claim. A paper on one ingredient does not automatically support a claim for a finished blend.

If a label carries a qualifying structure/function claim, the responsible firm generally must notify FDA no later than 30 days after first marketing. The statutory DSHEA disclaimer still applies. FDA's December 2025 enforcement discretion concerns the requirement to repeat the disclaimer on every panel carrying a claim; it does not remove the requirement to include and properly link the disclaimer.

Decision gate: Every proposed claim has approved language, appropriate support, an owner, and a defined use across every sales channel.

7. Qualify the manufacturer

A facility being “FDA registered” means that a registration requirement has been addressed. It does not mean FDA approved the facility's work or the finished product.

Ask potential manufacturers for evidence relevant to your product and channel:

• Current food-facility registration where required

• Dietary supplement CGMP systems under 21 CFR Part 111

• Recent third-party audit reports or certifications

• Experience with the dosage form and ingredients

• Supplier qualification procedures

• Identity testing and specification controls

• Master manufacturing and batch production records

• In-process and finished-product testing

• Deviation and out-of-specification procedures

• Product-release authority

• Stability program and shelf-life process

• Allergen, sanitation, pest-control, and environmental procedures

• Label and packaging controls

• Complaint, return, recall, and traceability systems

• Capacity, lead times, minimum orders, and change-control terms

Ask for a sample document set with sensitive details removed. A polished sales deck is less useful than seeing how the quality system records a failed test, supplier change, label revision, or reworked batch.

Clarify ownership in writing:

• Formula and manufacturing know-how

• Specifications and test methods

• Artwork, tooling, moulds, and plates

• Raw materials and excess packaging

• Work in progress and rejected product

• Records, retained samples, and certificates

• Responsibilities when a batch fails or a recall occurs

Use both a commercial agreement and a quality agreement. The purchase order sets price and quantity. The quality agreement assigns responsibilities for manufacturing, testing, release, complaints, changes, records, and recalls.

Visit or audit the facility when the product risk and order size justify it. Contract manufacturing transfers work; it does not transfer the brand's reputation.

8. Develop the formula and specifications

Formulation now has useful constraints: customer, position, target price, ingredient route, claim plan, format, and manufacturer capability.

Evaluate each prototype for:

• Dose and serving size

• Number and size of capsules or tablets

• Powder volume, mixability, taste, texture, and aftertaste

• Gummy load limits and water activity

• Excipient function and allergen implications

• Ingredient interactions and expected overage

• Sensitivity to light, oxygen, moisture, and heat

• Container compatibility

• Cost at pilot, first run, and larger runs

• Ease of daily use

Write finished-product specifications before commercial production. Define identity, purity, strength, composition, contaminants, physical characteristics, packaging, test methods, sampling, and acceptance criteria.

A certificate of analysis is useful only when it is compared with an approved specification and supported by appropriate methods and controls.

The test plan should follow the product's risks. Depending on the formula, it may include:

• Ingredient identity

• Potency or strength

• Microbiological limits

• Heavy metals

• Pesticides

• Residual solvents

• Mycotoxins

• Allergens

• Disintegration or dissolution

• Water activity or moisture

• Known adulterants

• Sport-prohibited substances

Independent certification can be valuable when it addresses a real customer or channel requirement. Choose the program by scope rather than badge recognition.

Decision gate: The formula, specification, test plan, commercial cost, and daily-use experience are all acceptable at the same time.

9. Establish shelf life and packaging protection

An expiry or best-by date needs a defensible basis. The product must remain within specification in the package in which it is sold.

Create a stability plan covering the relevant physical, chemical, microbiological, and sensory characteristics. Use the actual formula, container, closure, seal, desiccant, label, and expected storage conditions. Accelerated work can inform development, but it should not be treated as a substitute for an appropriate ongoing stability program.

Choose packaging from the product's protection needs:

• HDPE bottles: light, durable, and widely used for capsules, tablets, and gummies; barrier performance depends on the complete pack.

• PET bottles: clear and rigid, but light and moisture protection vary by resin, colour, wall, and closure.

• Glass: chemically inert and useful for some liquids or light-sensitive products; heavier and more vulnerable in shipping.

• Pouches and sachets: efficient for powders and unit doses when the laminate provides the necessary barrier.

• Blisters: protect individual doses and can improve adherence; tooling and line requirements can raise cost.

Also consider:

• Closure and liner

• Induction seal and tamper evidence

• Desiccant or oxygen control

• Child-resistant needs where applicable

• Fill volume and headspace

• Shipping heat, cold, pressure, drops, and vibration

• Ink, coating, adhesive, and scuff resistance

• Migration and product-contact compatibility

• Recyclability and the evidence needed for environmental claims

Run transit tests with the finished pack and shipper. Inspect leakage, breakage, label movement, scuffing, powder dust, seal failure, and customer usability.

A finish that looks expensive in a mockup and damaged after delivery is a poor material choice.

Decision gate: The pack protects the product, survives distribution, fits the label, and still looks intentional when it reaches the customer.

10. Build the brand system

The brand should be designed after the commercial and product direction is clear, but before the label is treated as a finished layout.

Build in this order:

1. Customer and position

2. Message hierarchy

3. Name and verbal system

4. Identity

5. SKU architecture

6. Packaging system

7. Website, marketplace, retail, and launch assets

The system has to work where customers will judge it: a search result, an Amazon grid, a shelf, a product page, a parcel, a subscription reminder, and a retailer's line sheet.

For premium supplements, the design must make four things easy to understand:

• What the product is

• Who it is for

• Why its price makes sense

• What evidence deserves attention

Premium does not require beige, serif type, foil, glass, or minimal copy. It requires control. The information is readable, the choices feel related, the product is recognisable at small sizes, and the packaging does not make claims the evidence cannot carry.

Test the system before final artwork:

• Thumbnail: Is the brand and product readable at 120 pixels?

• Grid: Does it remain distinct beside the closest competitors?

• Flash: After one second, what do people remember?

• Blur: Are the colour and structure recognisable without words?

• Price guess: Does the perceived price match the planned price?

Use target customers, not only the internal team. Record the questions, sample, competitor set, and results. Informal feedback is useful, but it is not the same as a blind test.

Decision gate: The packaging communicates the product and price quickly, remains recognisable across channels, and can extend to the next SKU without being rebuilt.

11. Complete the label

Treat the regulatory copy as part of the layout from the first mechanical.

A typical US dietary supplement label must account for:

• Statement of identity on the principal display panel

• Net quantity of contents

• Supplement Facts formatted under 21 CFR 101.36

• Other ingredients in the required order

• Name and place of business of the manufacturer, packer, or distributor

• Domestic address or phone number for adverse-event reports

• Allergen declaration where applicable

• Directions, warnings, and storage information where appropriate

• Lot and date coding plan

• DSHEA disclaimer when qualifying claims are used

Exact requirements depend on the product, claims, package, and business arrangement.

Review the full impression, including product name, flavour, icons, photographs, seals, footnotes, and nearby web copy. A visual can imply a disease claim as clearly as a sentence.

Run three reviews on the final artwork:

1. Regulatory: Required content, claims, disclaimers, and placement

2. Quality and manufacturing: Formula, serving, ingredients, warnings, codes, and production details

3. Prepress: Dieline, bleeds, quiet zones, minimum type, contrast, seams, curvature, barcode, and print specification

Inspect a physical proof on the actual container. A flat PDF does not show distortion, glare, seam interference, or small type around a bottle.

Obtain legitimate GTINs from GS1 US for sellable variations that need separate identifiers. Test the printed barcode rather than relying on the artwork preview.

Decision gate: Regulatory, quality, and prepress reviewers approve the same dated artwork file.

12. Build the operating system before launch

The brand needs procedures for the work that begins after the label is printed.

Assign responsibility for:

• Supplier and manufacturer qualification

• Batch review and product release

• Deviations and out-of-specification results

• Specifications and change control

• Artwork and claim approval

• Complaints and returns

• Adverse-event intake and escalation

• Recalls and market withdrawal

• Destruction and reconciliation

• Record retention

• State-law and marketplace monitoring

The company named on the label is generally the “responsible person” for serious adverse-event reporting. Serious reports must generally be submitted to FDA within 15 business days of receipt. Related records must be retained for six years. Train customer support to recognise a potential adverse event and route it promptly; a general inbox is not a procedure.

Food facilities required to register with FDA renew during October 1 through December 31 of each even-numbered year. 2026 is a renewal year. Confirm the registration status of relevant domestic and foreign facilities, including US-agent arrangements for foreign facilities.

State rules can affect sale and delivery. New York General Business Law § 391-oo restricts the sale to people under 18 of certain over-the-counter diet pills and dietary supplements marketed for weight loss or muscle building, with stated exceptions. Online brands should review product coverage, age verification, delivery, and state shipping logic with counsel. Similar proposals and requirements may arise elsewhere.

Marketplace policy is another layer. Amazon can require sellers to work with approved testing, inspection, and certification providers and can suppress listings when documentation is incomplete. Check the current Seller Central policy for each ASIN before production; marketplace requirements can change faster than federal regulations.

Decision gate: A named person can show how a lot is released, how a complaint is handled, how a serious event is escalated, and how affected units would be traced and recalled.

13. Approve the first production run

Freeze the approved production set before authorising the run:

• Formula and component specifications

• Approved suppliers

• Master manufacturing record

• Packaging and label files

• Sampling and testing plan

• Release criteria

• Stability protocol

• Purchase order and quality agreement

• Freight, warehouse, quarantine, and release process

Keep the first run small enough to survive a correction. Early changes are common: serving format, flavour, instructions, positioning, label hierarchy, pack performance, or channel strategy.

Do not release the lot because the launch date is close. Release it only after the authorised quality function has reviewed the batch records, deviations, test results, packaging, coding, and traceability against the approved requirements.

Keep reserve samples and records according to the applicable procedures and agreements.

Decision gate: Released inventory can be traced from finished unit to batch, components, results, and approved artwork.

14. Prepare the store and sales channels

A product page should answer questions in the order a customer needs them:

1. What is it?

2. Who is it for?

3. What does it support?

4. Why should I believe that?

5. How do I take it?

6. What is in it?

7. What should I know before using it?

8. How are shipping, subscriptions, and returns handled?

Use the approved claim library across the website, marketplace listings, retail copy, ads, email, affiliates, creators, and customer support. Testimonials and creator statements can become advertising claims. Material connections must be disclosed clearly under FTC requirements.

Prepare channel documents before stock arrives. Depending on the channel, this may include:

• Final label images

• Product and facility testing documents

• CGMP evidence

• Certificates and audit reports

• Ingredient and allergen information

• GTIN records

• Insurance certificate

• Lot and date information

• Case pack, dimensions, and weights

• Safety or technical documentation requested by the platform or retailer

Build proof that a customer can examine:

• Readable Supplement Facts and ingredient forms

• Plain-language explanation of dose and use

• Testing information with a defined scope

• Sourcing information that can be verified

• Real product photography at useful scale

• Comparison claims based on documented differences

• Clear warnings, directions, and contact information

Start building qualified demand before production finishes. A small list of relevant customers, practitioners, creators, retailers, or community partners is more valuable than a large audience with no connection to the problem.

Decision gate: The product can go live without writing new claims, chasing missing documents, or releasing quarantined inventory.

15. Run a controlled launch

Treat the first 30 to 90 days as a learning period, not proof that the business has already scaled.

Track:

• Conversion rate by source and page

• Acquisition cost and contribution margin

• First-order and subscription mix

• Refunds, cancellations, and reasons

• Customer questions and review language

• Complaints and adverse events

• Taste, format, packaging, and shipping failures

• Listing or claim rejections

• Inventory coverage and reorder timing

• Repeat purchase when enough time has passed

Diagnose problems separately.

Low conversion may come from poor traffic, unclear positioning, weak proof, a price mismatch, or unconvincing packaging. Weak repeat purchase may come from the product experience, routine difficulty, serving size, customer expectations, or lack of perceived value. A crushed carton is not a positioning problem. A confusing front label is not a formula problem.

Use controlled files and version numbers. When a claim, label, component, or supplier changes, record who approved it, when it takes effect, and which lots use it.

Scale after the operation can explain what is working and can repeat it without lowering quality.

A realistic launch timeline

Timelines depend on formula complexity, ingredient status, manufacturer capacity, test methods, packaging, certification, and stability work.

The phases can overlap. The gates should not. Identity work can begin while the formula is being refined; final label artwork cannot close until the serving, ingredients, claims, warnings, and container dimensions are stable.

Complete launch checklist

Customer and position

○ Specific customer and recurring problem defined

○ 15–20 relevant customer interviews completed

○ Current products and non-product substitutes mapped

○ One-sentence position tested for comprehension

○ First SKU and main reason to switch selected

Business and finance

○ Landed cost calculated

○ Contribution margin modelled by channel

○ Downside cash-flow case completed

○ Reorder timing and deposit included

○ Entity, tax, banking, and accounting set up

○ Product-liability and general-liability cover active

○ Trademark clearance completed

Product and claims

○ Product classification confirmed

○ Lawful basis documented for every ingredient

○ NDI assessment completed and notification filed if required

○ Safety review covers dose, population, and finished formula

○ Approved claim library created

○ Claim substantiation file complete

○ Structure/function notification responsibility assigned

Manufacturing and quality

○ Manufacturer and facility qualified

○ Commercial and quality agreements signed

○ Formula and specifications approved

○ Test methods, sampling, and release criteria approved

○ Stability and shelf-life plan documented

○ Supplier, complaint, adverse-event, change-control, and recall procedures active

○ 2026 facility-registration renewal responsibility confirmed

Brand and packaging

○ Name, message, identity, and SKU structure work as one system

○ Thumbnail, grid, flash, blur, and price tests completed

○ Package protects the formula and survives transit

○ Label approved by regulatory, quality, and prepress reviewers

○ GS1 identifiers assigned and printed barcodes tested

Commerce and launch

○ Website, listings, ads, creators, and support use the approved claims

○ Marketplace and retailer documents accepted

○ Inventory is released before sale

○ Complaint and adverse-event intake is live

○ Metrics and 30-, 60-, and 90-day reviews are scheduled

○ Reorder trigger is defined

Mistakes that cost the most

Designing the logo before the product is clear

The identity is built around assumptions that later change. Formula, claims, price, and customer decisions then force a new label or a compromised one.

Choosing the lowest manufacturing quote

A low quote can exclude testing, hide weak documentation, depend on unapproved substitutions, or come from a facility that cannot meet the intended channel's requirements.

Calling a product FDA approved

Most supplements are not FDA approved before sale. Facility registration, NDI notification, and structure/function notification do not create product approval.

Copying a competitor's claims

A live claim is not evidence that it is lawful or supported. It may be new, poorly reviewed, or awaiting enforcement.

Ordering for the best unit cost

The first run should buy learning as well as inventory. Flexibility can be worth more than the final reduction in unit cost.

Treating the back label as leftover space

The Supplement Facts, directions, warnings, business details, and claims need a controlled hierarchy. If customers cannot read or find them, the front label's trust is quickly lost.

Letting each channel write its own copy

A label, product page, ad, creator, and support script can create five different versions of the claim. Use one approved library and keep records of changes.

Frequently asked questions

How much does it cost to start a supplement brand?

There is no reliable universal figure. A stock formula in standard packaging costs far less than a custom product requiring development, certification, original testing, custom components, and a large first run. Budget for inventory, packaging, testing, regulatory and legal review, insurance, freight, fulfilment, customer acquisition, returns, and the next production deposit. The manufacturer's quote is only one part of the launch cost.

How long does it take to launch?

A straightforward product using established ingredients and stock packaging may take about six to nine months when decisions and documentation move cleanly. Novel ingredients, custom gummies, certifications, stability work, custom packaging, or delayed test methods can extend the schedule.

Do dietary supplements need FDA approval?

Most dietary supplements do not receive FDA premarket approval. The brand remains responsible for the product's safety, lawful ingredients, compliant manufacturing, label, claims, and post-market duties. Certain new dietary ingredients may require an NDI notification.

Can a private-label manufacturer handle compliance for the brand?

A good manufacturer can perform important manufacturing, quality, and documentation work. The brand should still qualify the facility, approve the formula and specifications, control claims and artwork, define responsibilities in a quality agreement, keep required records, and operate complaint and adverse-event processes.

Should a new brand launch one product or several?

One focused first SKU is usually easier to explain, stock, test, and improve. Several products make sense when the customer routine truly requires a system and the business can carry the extra development and inventory.

When should branding start?

Positioning and naming should start early. Full identity and packaging work should begin once the customer, product direction, claims, price, format, and channels are stable enough to design against. Final label artwork should wait for approved copy, formula, serving, warnings, and container specifications.

What does “third-party tested” mean?

It should identify an independent laboratory or certification program, the product or lot tested, the methods or standard used, the acceptance criteria, and the results or certification scope. The phrase alone does not explain what was tested.

Is mandatory FDA product listing required in July 2026?

No federal mandatory dietary supplement product-listing system is in force as of July 12, 2026. H.R. 8370 was introduced in April 2026 and remains proposed legislation. Check Congress.gov for later action before relying on this answer.